BRIEF-Shenzhen Hepalink Pharmaceutical to invest in Canada's Resverlogix Corp
October 13, 2017 at 07:10 AM EDT
* Says it plans to invest up to C$87 million ($69.75 million) in Canada's Resverlogix Corp
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.